Suppr超能文献

用于评估溶栓药物的小动物血栓形成模型。

Small animal thrombosis models for the evaluation of thrombolytic agents.

作者信息

Stassen J M, Lijnen H R, Kieckens L, Collen D

机构信息

Center for Thrombosis and Vascular Research, University of Leuven, Belgium.

出版信息

Circulation. 1991 Jun;83(6 Suppl):IV65-72.

PMID:2040073
Abstract

BACKGROUND

Two thrombosis models for the evaluation of thrombolytic agents in small animals (less than 100 g) were evaluated: an iodine-125 fibrin-labeled rat plasma clot in the inferior caval vein of 3-4-week-old rats and a pulmonary embolus in adult hamsters that had been obtained by injection of a 125I fibrin-labeled human plasma clot. The extent of thrombolysis was determined by continuous external monitoring of radioisotope over the thrombus region and by ex vivo recovery of residual clot.

METHODS AND RESULTS

In the rat model, infusion of solvent for 60 minutes was associated with mean +/- SEM lysis within 90 minutes of 13 +/- 3% (n = 8) by external counting and 26 +/- 4% (n = 8) by radioisotope recovery. Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) over 60 minutes caused dose-dependent progressive clot lysis; with 0.5 mg/kg, producing a plasma level of 0.14 +/- 0.04 microgram/ml, lysis was 64 +/- 9% (n = 4) by external gamma counting and 78 +/- 4% (n = 4) by residual isotope in the vein segment and was not associated with significant fibrinogen or alpha 2-antiplasmin breakdown. In the hamster model, infusion of solvent for 60 minutes was associated with lysis within 90 minutes of 19 +/- 4% (n = 11) by external gamma counting and 31 +/- 3% (n = 14) by residual radioisotope. Intravenous rt-PA during 60 minutes resulted in dose-dependent progressive thrombolysis; with 0.5 mg/kg, producing a plasma level of 0.14 +/- 0.01 micrograms/ml, lysis was 50 +/- 4% (n = 4) by external gamma counting and 78 +/- 5% (n = 4) by residual radioactivity, without an extensive decrease in fibrinogen or alpha 2-antiplasmin. Parallel experiments in the rabbit jugular vein thrombosis model with a rabbit blood clot with intravenous infusion over 4 hours produced 7 +/- 2% (n = 9) lysis with solvent and dose-dependent progressive lysis with rt-PA; with 1 mg/kg, producing a plasma level of 0.20 +/- 0.03 microgram/ml, lysis was 56 +/- 7% (n = 7) by external gamma counting and 61 +/- 7% (n = 7) by residual radioactivity, without extensive consumption of fibrinogen or alpha 2-antiplasmin.

CONCLUSIONS

These two thrombosis models in small animals are as reproducible and quantitative as the extensively used rabbit jugular vein thrombosis model. The hamster pulmonary embolism model is superior because it is simpler and more straightforward and allows the performance of as many as 10 experiments by one investigator in 1 day.

摘要

背景

评估了两种用于评价小动物(体重小于100克)溶栓药物的血栓形成模型:3至4周龄大鼠下腔静脉中碘-125纤维蛋白标记的大鼠血浆凝块模型,以及成年仓鼠肺栓塞模型,后者通过注射125I纤维蛋白标记的人血浆凝块获得。通过对血栓区域进行放射性同位素的连续外部监测以及通过体外回收残余凝块来确定溶栓程度。

方法与结果

在大鼠模型中,输注溶剂60分钟后,90分钟内通过外部计数平均溶解率为13±3%(n = 8),通过放射性同位素回收为26±4%(n = 8)。静脉输注重组组织型纤溶酶原激活剂(rt-PA)60分钟导致剂量依赖性的渐进性凝块溶解;0.5mg/kg剂量时,血浆水平为0.14±0.04μg/ml,通过外部γ计数溶解率为64±9%(n = 4),通过静脉段残余同位素为78±4%(n = 4),且与纤维蛋白原或α2-抗纤溶酶的显著降解无关。在仓鼠模型中,输注溶剂60分钟后,90分钟内通过外部γ计数溶解率为19±4%(n = 11),通过残余放射性同位素为31±3%(n = 14)。静脉输注rt-PA 60分钟导致剂量依赖性的渐进性溶栓;0.5mg/kg剂量时,血浆水平为0.14±0.01μg/ml,通过外部γ计数溶解率为50±4%(n = 4),通过残余放射性为78±5%(n = 4),纤维蛋白原或α2-抗纤溶酶无大量减少。在兔颈静脉血栓形成模型中,对兔血凝块静脉输注4小时,溶剂导致7±2%(n = 9)溶解,rt-PA导致剂量依赖性的渐进性溶解;1mg/kg剂量时,血浆水平为0.20±0.03μg/ml,通过外部γ计数溶解率为56±7%(n = 7),通过残余放射性为61±7%(n = 7),纤维蛋白原或α2-抗纤溶酶无大量消耗。

结论

这两种小动物血栓形成模型与广泛使用的兔颈静脉血栓形成模型一样具有可重复性和定量性。仓鼠肺栓塞模型更优,因为它更简单直接,一名研究人员一天内可进行多达10次实验。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验